Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research

Author： Vormfelde Stefan Viktor   Burckhardt Gerhard   Zirk Alexandra   Wojnowski Leszek   Brockmöller Jürgen  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.6, 2003-11, pp. : 701-734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

South Korea's regulatory authority has amended data requirements for the designation of orphan drugs for rare and life-threatening diseases

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

South Korea's regulatory authority has amended data requirements for the designation of orphan drugs for rare and life-threatening diseases

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest articles in pharmacogenomics of antihypertensive drugs

By Cerda Alvaro   Hirata Rosario DC   Hirata Mario H  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1817-1820

Future Medicine

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest articles in pharmacogenomics of oral antidiabetic drugs

By Tkáč Ivan  

Pharmacogenomics, Vol. 13, Iss. 12, 2012-09 ,pp. : 1329-1332

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Oral Antithrombotic Drugs

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1933-1949

Bentham Science Publishers

Access to resources Recommend Favorite